Antidepressant and Double Antidepressant Treatment for the Affective Disorder of Epilepsy
The DOI matches its Crossref record.
Abstract
BACKGROUND: About half of all patients with chronic epilepsy experience an intermittent and polysymptomatic affective disorder; fewer than 10% suffer from interictal psychotic episodes. The affective disorder responds well to treatment with tricyclic antidepressant medication. The interictal psychosis tends to develop among those with severe affective disorder, responds poorly to antipsychotic medication, and has been more difficult to treat. METHOD: At the Epi-Care Center, Memphis, Tennessee, we have recently begun to treat refractory cases, both nonresponders with affective disorder and those with interictal psychosis, with the combination of a tricyclic antidepressant (TCA) and a serotonin selective reuptake inhibitor (SSRI). The double antidepressant treatment of all previously intractable patients with interictal affective disorder seen over a 20-month period at the Epi-Care Center is reported here. RESULTS: The outcome of the novel treatment for the most severe psychiatric disorders of epilepsy has been highly satisfactory: 15 (68%) of 22 previously unresponsive patients with affective disorder were excellent or good responders. CONCLUSION: Antidepressants are the psychotropic drugs of choice for the affective disorder of epilepsy and can be effective in combined form (TCA and SSRI) for otherwise intractable patients. The paradoxical therapeutic effects of proconvulsant drugs in epilepsy conform with the hypothesis that the psychiatric complications of chronic epilepsy result from the development of seizure-suppressing mechanisms that can be mitigated by antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prevalence and incidence studies of anxiety disorders: A systematic review of the literature
Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100206 · Cited by 1,114
Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy
Boylan, L. S., Flint, L. A., Labovitz, D. L., Jackson, S. C., Starner, K., & Devinsky, O. (2004) · Neurology · doi:10.1212/01.wnl.0000103282.62353.85 · Cited by 644
The etiology, biology, and evolving pathology of premenstrual syndromes
Halbreich, U. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00097-0 · Cited by 306
Depression and comorbidity in community-based patients with epilepsy or asthma
Ettinger, A., Reed, M., & Cramer, J. (2004) · Neurology · doi:10.1212/01.wnl.0000138430.11829.61 · Cited by 302
Depression and Anxiety in People with Epilepsy
Kwon, O.-Y., & Park, S.-P. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.3.175 · Cited by 294
Depression in Epilepsy: Etiology, Phenomenology, and Treatment
Lambert, M. V., & Robertson, M. M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00884.x · Cited by 293
Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
Brodie, M. J., Besag, F., Ettinger, A. B., Mula, M., Gobbi, G., Comai, S., Aldenkamp, A. P., & Steinhoff, B. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012021 · Cited by 288
Pathophysiology of depression and mechanisms of treatment
Brigitta, B. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.1/bbondy · Cited by 286
Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders
Barry, J. J., Ettinger, A. B., Friel, P., Gilliam, F. G., Harden, C. L., Hermann, B., Kanner, A. M., Caplan, R., Plioplys, S., Salpekar, J., et al. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.04.005 · Cited by 249
Depression in Epilepsy: Ignoring Clinical Expression of Neuronal Network Dysfunction?
Gilliam, F. G., Santos, J., Vahle, V., Carter, J., Brown, K., & Hecimovic, H. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.452005.x · Cited by 210
“Blumer (31) subsequently reported the results of an openlabel, uncontrolled study of the addition of a seratonin reuptake inhibitor in 22 patients who had not responded to a tricyclic antidepressant.”
BackgroundBlumer, D., Montouris, G., & Davies, K. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.08.003 · Cited by 188
“Affective changes among patients with epilepsy have been viewed as symptoms of a depressive or other psychiatric disorder defined by the merely descriptive criteria of the conventional DSMIV classification [3], instead of being recognized as a unique disorder based on specific etiology and requiring specific treatment…”
BackgroundResultSelf-citationLimbic reductions of 5-HT 1A receptor binding in human temporal lobe epilepsy
Savic, I., Lindström, P., Gulyás, B., Halldin, C., Andrée, B., & Farde, L. (2004) · Neurology · doi:10.1212/01.wnl.0000123696.98166.af · Cited by 183
Combining Pharmacotherapy with Cognitive‐Behavioral Interventions for Obsessive‐Compulsive Disorder
Cottraux, J., Bouvard, M. A., & Milliery, M. (2005) · Cognitive Behaviour Therapy · doi:10.1080/16506070510043750 · Cited by 60
Antidepressants for people with epilepsy and depression
Maguire, M. J., Marson, A. G., & Nevitt, S. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010682.pub3 · Cited by 57
Identifying Persons at Risk for PTSD After Trauma with TSQ in The Netherlands
Dekkers, A. M. M., Olff, M., & Näring, G. W. B. (2010) · Community Mental Health Journal · doi:10.1007/s10597-009-9195-6 · Cited by 57
Kwak, S., Kim, M., Kim, T., Kwak, Y., Oh, S., Lho, S. K., Moon, S.-Y., Lee, T. Y., & Kwon, J. S. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01045-4 · Cited by 22
Metadata
- Authors
- Blumer, D.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1997-01-15
- Volume
- 58
- Issue
- 1
- Pages
- 3-11
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2066622866
- Cited by
- 146
- References
- 0
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.